Our multi-omic study on CYLD Cutaneous Syndrome (CCS) tumors unveils cells of origin of cylindromas (apocrine sweat glands), and of trichoepitheliomas (closer to BCC). Plus, a key finding: non-canonical NF-κB pathway activation – a new therapeutic avenue!
doi.org/10.1016/j.jid.2025.0…
6
Calling all #Bioinformatics & #ComputationalEngineers!
Unravel cancer mutation mysteries at Gustave Roussy, Europe's top cancer center!
Join our team! Analyze massive #WGS data & unlock secrets of damage-induced mutagenesis in cancer.
linkedin.com/hiring/jobs/398…
21
Sergey Nikolev retweeted
We know how will be the next Research Building @GustaveRoussy (Q1 2027)
32 000 m2 , 60 research teams in 15 Centers, 15 core facilities, 1400 staff. Each floor will include 10 teams of biology that will surround Data Science / Epidemiology teams. We are welcoming new teams !
Sergey Nikolev retweeted
❓Could the use of WGS, WES, and RNAseq over targeted NGS improve the yield and uptake of precision medicine?
📰@mihaela_aldea @snikolae and coll. discuss this topic in this Editorial in Annals of Oncology:
annalsofoncology.org/article…
2/2
Sergey Nikolev retweeted
⭐️ NEW RESEARCH @CommsMedicine - Yurchenko et al. report clinical & genomic findings in a series of DNA repair-deficient xeroderma pigmentosum group C patients with early-onset gynecological tumors | @a_a_yurchenko88 @snikolae @GustaveRoussy @UMR981
nature.com/articles/s43856-0…
What is the genetic mechanism underlying a risk of gynecological malignancies (GM) in xeroderma pigmentosum? Proud to present our study: XPC deficiency causes mutator phenotype in GM and manifests in a mutational profile independent of tissue of origin. rdcu.be/djeZf
1
62
Sergey Nikolev retweeted
What are the main causes of spontaneous mutagenesis? Proud to present our new paper reporting that translesion synthesis (REV1) or oxidative processes (via PRIMPOL) are responsible for mutations in cultured human cells cell.com/cell-reports/fullte…
Sergey Nikolev retweeted
In the May issue—
Integrative #Pancancer Genomic and Transcriptomic Analyses of Refractory #Metastatic Cancer, by @ypradat, @DGautheret, @snikolae et al.
https://xitter.gq/t.co/TbyTDECzpP
@PrismCenter @GustaveRoussy @centralesupelec @ParisSaclay @Inserm
Sergey Nikolev retweeted
🚨 Delighted to share our back-to-back publications in @Nature (nature.com/articles/s41586-0…) and @NatureGenetics (nature.com/articles/s41588-0…)🚨. In these publications we unravel the pan-cancer immunogenomics differences between primary and metastatic tumors. Thread below🧵👇
Sergey Nikolev retweeted
💡 Learn about the genetic basis of skin cancer risk in #XerodermaPigmentosum, and the mechanisms reducing UV-induced #mutagenesis in the general population.
👏 Kudos to @a_a_yurchenko88, @snikolae, @Tirzahbp & colleagues on a great @NatureComms study!
📓 go.nature.com/3VPNAML
Sergey Nikolev retweeted
Analysis of skin cancer genomes from xeroderma pigmentosum patients to study the role of defects in the components of NER and translesion synthesis on TMB, mutation profiles and genomic landscape of mutagenesis. #MutationalSignature #CancerResearch #DNA
nature.com/articles/s41467-0…
Sergey Nikolev retweeted
Cool genomics findings from UV hypermutated cancers w/deficient DNA repair or TLS. E.g:
☀️transcription-coupled NER can extend quite a bit away from the 3' end of genes
☀️insights into roles of POLH enzyme in managing some v abundant and poorly studied UV 🧬dmgs at TG, TA
➕more
Analysis of skin cancer genomes from xeroderma pigmentosum patients to study the role of defects in the components of NER and translesion synthesis on TMB, mutation profiles and genomic landscape of mutagenesis. #MutationalSignature #CancerResearch #DNA
nature.com/articles/s41467-0…
Our study on mutagenesis in skin cancer from xeroderma pigmentosum patients came out online today in Nature Communications.
nature.com/articles/s41467-0… – at Carnac, France
Sergey Nikolev retweeted
Huge #OpenAccess resource paper in @CD_AACR from @GustaveRoussy:
Integrative Pan-Cancer Genomic and Transcriptomic Analyses of Refractory Metastatic Cancer 👉🏽
META-PRISM cohort of 1,031 refractory metastatic tumors with comprehensive molecular profiling.
aacrjournals.org/cancerdisco…
I am proud of our study from Gustave Roussy and Paris-Saclay that came out in Cancer Discovery. It reports molecular markers from wes and rnaseq in a large cohort of refractory cancers and establishes their potential for prediction of 6-month survival.
aacrjournals.org/cancerdisco… – at South Sinai, Egypt
Analysis of Skin Cancers from Xeroderma Pigmentosum Patients Reveals Heterogeneous UV-Induced Mutational Profiles Shaped by DNA Repair biorxiv.org/content/10.1101/… – at Le Vaudoué, France
Sergey Nikolev retweeted
Tks anirban !
RNA seq and whole exome in 1000 and 500 pretreated metastatic cancers. Interesting to see the impact of prior therapies, especially platinum, on DNA + discovery of new alterations involved in resistance (PTEN transloc). A huge work from PRISM (maybe futur center🤞)
Preprint from @ypradat @FAndreMD et al @PrismCenter @GustaveRoussy:
Integrative pan-cancer genomic and transcriptomic analyses of refractory metastatic cancer
medrxiv.org/content/10.1101/…
Whole exome & transcriptome sequencing on >1,000 metastatic tumors including #PancreaticCancer





















